Breaking News Instant updates and real-time market news.

SHPG

Shire

$126.32

-0.76 (-0.60%)

11:22
02/27/18
02/27
11:22
02/27/18
11:22

Shire reports EMA accelerated assessment for lanadelumab

Shire announced the Committee for Medicinal Products for Human Use of the European Medicines Agency, or EMA, has granted an accelerated assessment for lanadelumab, an investigational treatment being evaluated for the prevention of angioedema attacks in patients 12 years and older with the rare, genetic disorder, hereditary angioedema, or HAE. Shire is on track to submit its EU Marketing Authorization Application in the coming weeks, the company stated, adding that accelerated assessments by the CHMP of a marketing authorization filed under the centralized European procedure reduces the amount of evaluation days required, from 210 to 150.

  • 23

    Mar

  • 25

    Mar

SHPG Shire
$126.32

-0.76 (-0.60%)

02/20/18
JPMS
02/20/18
DOWNGRADE
Target $150
JPMS
Neutral
JPMorgan sees few catalysts for Shire, downgrades shares to Neutral
JPMorgan analyst James Gordon yesterday downgraded Shire to Neutral while lowering his price target for the shares to $150 from $200. The analyst sees few catalysts in 2018 and 2019 beyond a potential NeuroScience spinoff, which he does not see as creating fundamental value. Further, he believes the "Haemophilia overhang" will likely to weigh on Shire's Rare Disease business over the next two years.
02/20/18
RHCO
02/20/18
NO CHANGE
Target $190
RHCO
Buy
Shire price target lowered to $190 from $260 at SunTrust
SunTrust analyst John Boris lowered his price target on Shire to $190, citing expectations of lower Factor VIII sales from higher Hemlibra risk along with higher costs associated with Covington manufacturing facility. The analyst keeps his Buy rating, saying the expected second-half of 2018 launch of Lanadelumab, as well as the strategic decision on the Neuroscience business, are potential upside catalysts for Shire.
02/20/18
02/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Sell from Neutral at Citi with analyst Mark May saying the recent flagship app redesign could produce positive long-term benefits, but the "significant jump" in negative app reviews since the redesign was pushed out a few weeks could result in a decline in users and user engagement, and could negatively impact financial results. 2. Wingstop (WING) downgraded to Neutral from Outperform at Baird with analyst David Tarantino citing the recent surge in the shares, which has left less room for upside on a near-term basis. 3. Northrop Grumman (NOC) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Noah Poponak citing valuation. 4. JPMorgan sees few catalysts for Shire (SHPG), downgrades shares to Neutral with analyst James Gordon saying he sees few catalysts in 2018 and 2019 beyond a potential NeuroScience spinoff, which he does not see as creating fundamental value. 5. Teck Resources (TECK) downgraded to Neutral from Outperform at Macquarie with analyst Matt Murphy citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/22/18
BOFA
02/22/18
NO CHANGE
BOFA
Buy
Shire post results weakness overdone, says BofA/Merrill
BofA/Merrill analyst Graham Parry believes Shire post results weakness is overdone and says shares remain undervalued. The analyst argued that cons EPS cuts are already priced in, and reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

BV

BrightView

$21.95

0.14 (0.64%)

05:12
07/23/18
07/23
05:12
07/23/18
05:12
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCDA

Tricida

$29.50

-0.42 (-1.40%)

05:10
07/23/18
07/23
05:10
07/23/18
05:10
Initiation
Tricida initiated  »

Tricida initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BV

BrightView

$21.95

0.14 (0.64%)

05:08
07/23/18
07/23
05:08
07/23/18
05:08
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$24.98

-0.12 (-0.48%)

05:07
07/23/18
07/23
05:07
07/23/18
05:07
Initiation
Insmed initiated  »

Insmed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 28

    Sep

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:04
07/23/18
07/23
05:04
07/23/18
05:04
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:01
07/23/18
07/23
05:01
07/23/18
05:01
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$80.64

-0.56 (-0.69%)

04:58
07/23/18
07/23
04:58
07/23/18
04:58
Upgrade
Duke Energy rating change  »

Duke Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

STI

SunTrust

$70.86

1.855 (2.69%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Upgrade
SunTrust rating change  »

SunTrust upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGEN

Miragen Therapeutics

$6.87

-0.08 (-1.15%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Miragen Therapeutics management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
RBC Capital commodity strategist to hold a dinner meeting »

Commodity Strategist…

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

SAR

Saratoga Investment

$24.59

0.08 (0.33%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Saratoga Investment management to meet with Compass Point »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

NTEC

Intec Pharma

$4.75

(0.00%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Intec Pharma management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Chicago Fed National Activity Index Level to be reported at 08:30 »

June Chicago Fed National…

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Existing Home Sales to be reported at 10:00 »

June Existing Home Sales…

CCLAY

Coca-Cola Amatil

$0.00

(0.00%)

04:52
07/23/18
07/23
04:52
07/23/18
04:52
Downgrade
Coca-Cola Amatil rating change  »

Coca-Cola Amatil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

03:05
07/23/18
07/23
03:05
07/23/18
03:05
General news
FX Update: The dollar remained on a softening track »

FX Update: The dollar…

AGIO

Agios Pharmaceuticals

$91.06

-0.23 (-0.25%)

, CELG

Celgene

$85.09

-0.26 (-0.30%)

20:07
07/22/18
07/22
20:07
07/22/18
20:07
Recommendations
Agios Pharmaceuticals, Celgene analyst commentary at Piper Jaffray »

Agios' Tibsovo…

AGIO

Agios Pharmaceuticals

$91.06

-0.23 (-0.25%)

CELG

Celgene

$85.09

-0.26 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 21

    Aug

SYNT

Syntel

$39.15

0.14 (0.36%)

, FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

19:25
07/22/18
07/22
19:25
07/22/18
19:25
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

SYNT

Syntel

$39.15

0.14 (0.36%)

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

PM

Philip Morris

$84.31

3.41 (4.22%)

RACE

Ferrari

$139.98

-2.65 (-1.86%)

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

NFLX

Netflix

$361.33

-2.81 (-0.77%)

TSLA

Tesla

$313.49

-6.85 (-2.14%)

SNE

Sony

$52.97

0.355 (0.67%)

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

BLK

BlackRock

$503.01

-1.42 (-0.28%)

BEN

Franklin Resources

$31.99

-0.28 (-0.87%)

IVZ

Invesco

$25.46

-0.245 (-0.95%)

LM

Legg Mason

$33.37

-0.13 (-0.39%)

TROW

T. Rowe Price

$119.87

-0.85 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 06

    Aug

  • 07

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

INDB

Independent Bank

$88.10

6.45 (7.90%)

17:48
07/22/18
07/22
17:48
07/22/18
17:48
Upgrade
Independent Bank rating change at Keefe Bruyette »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHLB

Berkshire Hills Bancorp

$41.40

0.45 (1.10%)

17:47
07/22/18
07/22
17:47
07/22/18
17:47
Downgrade
Berkshire Hills Bancorp rating change at Keefe Bruyette »

Berkshire Hills…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Acquired by T

$0.00

(0.00%)

, CMCSA

Comcast

$34.30

-0.61 (-1.75%)

17:14
07/22/18
07/22
17:14
07/22/18
17:14
Hot Stocks
Box Office Battle: 'Equalizer 2' beats 'Mamma Mia: Here We Go Again!' »

Sony's (SNE)…

TWX

Acquired by T

$0.00

(0.00%)

CMCSA

Comcast

$34.30

-0.61 (-1.75%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$52.97

0.355 (0.67%)

FOX

21st Century Fox

$45.69

-0.5 (-1.08%)

FOXA

21st Century Fox

$46.01

-0.54 (-1.16%)

LGF.A

Lionsgate

$24.88

-0.08 (-0.32%)

DIS

Disney

$111.48

-0.66 (-0.59%)

VIAB

Viacom

$27.49

-0.51 (-1.82%)

VIA

Viacom

$32.10

-0.3 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 07

    Aug

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

BGNE

BeiGene

$169.98

5.95 (3.63%)

16:43
07/22/18
07/22
16:43
07/22/18
16:43
Hot Stocks
BeiGene planning to pursue accelerated approval in U.S. of Zanubrutinib in WM »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.